SCHEMBL30935187

SCHEMBL30935187

CC(C)(C)OC(=O)N1CC2(CNC(=O)c3ccc(Br)cc32)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 2/20 0.41
▸ CDK1 P06493 2/20 0.39
▸ CCNB2 O95067 1/20 0.39
▸ CCNB1 P14635 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ CCNB3 Q8WWL7 1/20 0.39
▸ ALK Q9UM73 1/20 0.38
▸ GPR119 Q8TDV5 2/20 0.38
▸ USP30 Q70CQ3 3/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ DDB1 Q16531 1/20 0.36
▸ CRBN Q96SW2 1/20 0.36
▸ NR1H2 P55055 2/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ BACE1 P56817 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30935122 0.90 USP30 (0.41) RORCCDK1CCNB2CCNB1GSK3B
SCHEMBL30935054 0.81 USP30 (0.41) RORCALKGPR119USP30DDB1
SCHEMBL16086112 0.77 USP30 (0.45) RORCGPR119USP30NR1H2ESR2
SCHEMBL16086822 0.77 USP30 (0.45) RORCGPR119USP30NR1H2ESR2
SCHEMBL16086326 0.77 USP30 (0.45) RORCGPR119USP30NR1H2ESR2
SCHEMBL1466048 0.76 ESR2 (0.42) RORCCDK1CCNB2CCNB1GSK3B
SCHEMBL17586451 0.75 RORC (0.42) RORCCDK1CCNB2CCNB1GSK3B
SCHEMBL26176388 0.75 ALK (0.42) RORCALKGPR119USP30PDK2
SCHEMBL31694099 0.75 ALK (0.42) RORCALKGPR119USP30PDK2
SCHEMBL6524496 0.74 GPR119 (0.41) RORCALKGPR119USP30CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024125464-A1 TETRAHYDROISOQUINOLIN-ONE DERIVATIVES, PREPARATION METHODS AND MEDICINAL USES THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2024-06-20 — — WO disclosed
Send feedback